Axsome Therapeutics Inc (AXSM)
74.86
+1.18
(+1.59%)
USD |
NASDAQ |
Apr 30, 13:16
Axsome Therapeutics Cash and Short Term Investments (Quarterly): 386.19M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 386.19M |
| September 30, 2023 | 416.56M |
| June 30, 2023 | 437.11M |
| March 31, 2023 | 246.52M |
| December 31, 2022 | 200.84M |
| September 30, 2022 | 227.52M |
| June 30, 2022 | 73.39M |
| March 31, 2022 | 84.71M |
| December 31, 2021 | 86.47M |
| September 30, 2021 | 114.62M |
| June 30, 2021 | 141.22M |
| March 31, 2021 | 164.66M |
| December 31, 2020 | 183.88M |
| September 30, 2020 | 202.36M |
| June 30, 2020 | 190.68M |
| March 31, 2020 | 197.31M |
| December 31, 2019 | 219.97M |
| September 30, 2019 | 43.64M |
| Date | Value |
|---|---|
| June 30, 2019 | 53.75M |
| March 31, 2019 | 42.62M |
| December 31, 2018 | 13.97M |
| September 30, 2018 | 15.22M |
| June 30, 2018 | 20.35M |
| March 31, 2018 | 26.63M |
| December 31, 2017 | 34.02M |
| September 30, 2017 | 31.67M |
| June 30, 2017 | 37.99M |
| March 31, 2017 | 45.02M |
| December 31, 2016 | 36.62M |
| September 30, 2016 | 33.89M |
| June 30, 2016 | 38.75M |
| March 31, 2016 | 44.08M |
| December 31, 2015 | 48.04M |
| September 30, 2015 | 4.621M |
| June 30, 2015 | 6.414M |
| December 31, 2014 | 2.618M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
43.64M
Minimum
Sep 2019
437.11M
Maximum
Jun 2023
193.23M
Average
190.68M
Median
Jun 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| Amgen Inc | 10.94B |
| Vertex Pharmaceuticals Inc | 11.22B |
| Krystal Biotech Inc | 532.18M |
| Alnylam Pharmaceuticals Inc | 2.439B |
| Catalyst Pharmaceuticals Inc | 137.64M |